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Introduction
Constipation is a condition in which bowel movements
are infrequent, irregular, or difficult.1 It is a disorder
resulting from different causes such as insufficient
intake of dietary fiber, emotional influence, dysfunction
of the nervous system, structural abnormality, systemic
disease, or drug effects.1 Constipation is a common
gastrointestinal problem worldwide, and it affects at
least 8.5% of individuals in Taiwan, based on Rome II
diagnostic criteria.2 It often occurs in females, with
advanced age, low socioeconomic class and low educa-
tional position.2,3
The aim of treating constipation is to treat the un-
derlying causes, improve symptoms, and resume the
normal physiological function of the bowel. Treating
constipation can be a comprehensive therapy tailored to
the individual.4 Drugs commonly used include bulk lax-
atives, osmotic laxatives, non-absorbable sugar, stimu-
lant laxatives, cholinergic agents and other prokinetic
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agents. Selective chloride channel activators, which can
increase intestinal water secretion, thereby increasing
intestinal motility and facilitating the bowel movement,
are also used.4,5
After excluding secondary constipation caused by
other problems, primary (idiopathic) constipation can
be classified into 3 categories: normal transit or irrita-
ble bowel syndrome, pelvic floor dysfunction, and slow
transit constipation. These 3 types of constipation over-
lap frequently. Normal and slow transit constipation are
usually treated by the drugs mentioned above.5 In
Eastern countries, traditional Chinese medicine (TCM)
is another option in addition to Western medicine for
treating constipation.6 The principles of diagnosis and
treatment of constipation in TCM are primarily based
on the manifestations of the syndrome Therefore, the
principal signs and symptoms of patients from which
a corresponding prescription of Chinese herbal medi-
cine (CHM) is provided, is largely dependent on the
experience of the Chinese herbal doctors or from the
records of ancient Chinese books. The optimal choice
of CHM prescription for constipation is unknown.
Furthermore, whether these Chinese herbs or formulae
have modern pharmacological effects in the treatment
of constipation remains to be elucidated.
In Taiwan, the National Health Insurance (NHI)
has reimbursed medical expenses for Western medicine
for nearly all inhabitants since 1995 (22,134,270 bene-
ficiaries at the end of 2004, covering nearly 98% of the
total population in Taiwan).7,8 The use of TCM has
been reimbursed by the NHI since 1996. People in
Taiwan are free to choose Western medicine or TCM,
and are allowed to visit primary care clinics or hospitals
without referral. Because all claims data are available to
researchers in electronic form, a large-scale survey of
pharmacoepidemiological issues can be easily con-
ducted. The aim of the current study was to explore the
frequency and pattern of CHM use for subjects with
constipation by analyzing the NHI database in 2004 in
Taiwan.
Methods
Data sources
The NHI program in Taiwan was initiated in 1995, and
the Bureau of the NHI began to release all claims data
in electronic form to the public under the National
Health Insurance Research Database (NHIRD) project
since 1999. The structure of the claims files is described
in detail on the NHIRD website and in our previous
report.6 Briefly, we obtained the database of TCM
claims, including the visit files and prescription files
(CM_CD2004.DAT and CM_OO2004.DAT), for
2004 from the NHIRD in Taiwan. The visit files re-
corded the dates of encounters, the medical care facili-
ties and specialties, patients’ sex, birth date, and up to 3
diagnoses according to the International Classification
of Diseases, 9th Revision, Clinical Modification (ICD-9-
CM). For privacy protection, the identification data of
patients and institutions was scrambled cryptographi-
cally to ensure anonymity. The prescription files con-
tained the prescription records of CHM corresponding
to the office visits. A CHM prescription contains 1 to
several single Chinese herbs or herbal formulae. The
Chinese herbal formulae or single herbs are made in
powder or fine granules in Taiwan, and can be easily
mixed and dispensed into small packages so that 1 pre-
scription can be taken at a time.
All TCMs are provided only in ambulatory clinics
under the coverage of NHI in Taiwan and there is no
inpatient care. In addition, only licensed TCM physi-
cians are qualified for reimbursement. The insurance
benefits of TCM in Taiwan include CHM, acupuncture
and traumatology manipulative therapy, especially for
joint dislocation.
Study design
Although the concept of disease entities in TCM is
quite different from that in Western medicine, the
TCM physicians in Taiwan are requested to make the
diagnosis based on ICD-9-CM coding for visiting
claims. In this study, we utilized the data of subjects
with the single diagnostic code for constipation (i.e.
ICD-9 code 564.0) among TCM visits.
According to the theory of TCM, a single prescrip-
tion from a TCM physician may contain a single Chi-
nese herb or multiple herbs of various dosages, namely
a compound (Fu-Fang) or a classical formula (regimen,
remedy or Fang-Ji). These are a combination of com-
patible Chinese herbs in fixed dosages ascribed to clas-
sical or well-known Chinese textbooks of medicine, or
a classical formula plus some Chinese herbs called Chia-
Chien-Fang. In addition, several formulae can be put
together with or without 1 or several Chinese herbs for
different symptoms and signs manifested by a patient.
Data analysis
The database software, IBM DB2 version 8.1 (IBM,
Armonk, NY, USA), was used for data linkage and pro-
cessing. Regular statistics (mean and percentage) were
displayed for the frequency of use and pattern of CHM
prescriptions for constipation. Association rule min-
ing, originally developed in the 1990s to identify which
groups or sets of items were likely to be purchased
together in the market, was applied to calculate the
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prescription of the Chinese herbs for constipation.9,10
An association rule was applied to prescriptions as fol-
lows: when a physician prescribes drug A (or drugs
{A1,A2}, drugs {A1,A2,A3}, etc.), he/she will also pre-
scribe drug B in X% of cases, and this co-prescribing is
present in Y% of all prescriptions. The support factor
is the ratio of co-prescriptions of all prescriptions (i.e.
Y% in the above example). The confidence factor is the
ratio of co-prescriptions to prescriptions for drug A
(i.e. X% in the above example). For executing the pro-
gram to identify association rules in our dataset, we
chose 0.5% as the minimum support factor and 30%
as the minimum confidence level.11
Results
Epidemiology
Among the 22,134,270 valid beneficiaries of the NHI
at the end of 2004 in Taiwan, 6,224,436 (28.1%) sub-
jects had used TCM during that year, and 152,564
(2.5%) subjects visited the TCM clinics and used CHM
only for constipation. Among these constipation sub-
jects, there were a total of 387,268 CHM prescriptions.
The peak age of subjects with constipation treated by
TCM was between 20 and 29 years of age (25.5%), fol-
lowed by 30–39 years of age (19.4%), and 40–49 years
of age (15.7%; Table 1). Female subjects used CHM
for constipation more frequently than male subjects
(female:male = 3.31:1).
Chinese herbal formulae
Ma-zi-ren-wan (34.4%) was the most commonly pre-
scribed Chinese herbal formula for subjects with 
constipation, followed by Fang-feng-tong-sheng-san
(17.6%), Run-chang-wan (12.4%), Run-chang-tang
(7.7%), Da-chai-hu-tang (6.6%), Ping-wei-san (4.9%),
Mu-xiang-bin-lang-wan (4.8%), San-huang-xie-xin-tang
(4.7%), Tao-ren-cheng-qi-tang (4.6%), and Gan-lu-
yin (4.5%; Table 2).
Single Chinese herbs
The most common single Chinese herb prescribed 
for constipation was Rheum palmatum (Da-huang)
(18.4%), followed by Magnolia officinalis (Hou-pu)
(6.6%), Scrophularia ningpoensis (Xuan-shen) (6.3%),
Citrus aurantium (fruit; Zhi-shi) (6.1%), Rehmannia
glutinosa (Sheng-di-huang) (6.0%), Ophiopogon japon-
icus (Mai-dong) (6.0%), Crataegus pinnatifida (Shan-
zha) (5.7%), Cannabis sativa (Huo-ma-zen) (5.1%),
Glycyrrhiza uralensis (Gan-cao) (5.0%), and Citrus
aurantium (peel; Zhi-ke) (4.5%; Table 3).
Combination of CHM
There was an average of 4.6 Chinese herbal items in a
single prescription for subjects with constipation. The
most common number of items in the prescription of
Chinese herbal formulae or single Chinese herbs for
subjects with constipation in Taiwan is 5 (16.6%), fol-
lowed by 4 (16.5%), and 3 (15.3%; Figure 1). Ac-
cording to the association rule, the most commonly
prescribed pattern of a 2-drug combination of CHM
for treating constipation was Ban-xia-xie-xin-tang plus
Ma-zi-ren-wan (Table 4), while the 3-drug combina-
tion of CHM was Fang-feng-tong-sheng-san, Rheum
palmatum and Ma-zi-ren-wan (Table 5). The most
common 4-drug combination of CHM for constipa-
tion was Ophiopogon japonicus, Rehmannia glutinosa,
Scrophularia ningpoensis and Run-chang-wan, which
accounted for 0.3% of all prescriptions. The most com-
mon 5-drug combination of CHM was An-zhong-san,
Mu-xiang-bin-lang-wan, Run-chang-tang, Fang-feng-
tong-sheng-san and Ma-zi-ren-wan, which accounted
for 0.2% of all prescriptions.
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Table 1. Age-specific frequency of the use of TCM in patients with constipation in Taiwan during 2004*
Age (yr)
Subjects with constipation using TCM
Total patients Males† Females†
0–9 11,013 (7.2) 4,997 (3.3) 6,016 (3.9)
10–19 16,713 (11.0) 3,716 (2.4) 12,997 (8.6)
20–29 38,961 (25.5) 4,203 (2.8) 34,758 (22.7)
30–39 29,969 (19.6) 4,279 (2.8) 25,690 (16.8)
40–49 23,938 (15.7) 4,480 (2.9) 19,458 (12.8)
50–59 11,607 (7.6) 3,311 (2.2) 8,296 (5.4)
60–69 7,621 (5.0) 3,275 (2.1) 4,346 (2.9)
70–79 8,968 (5.9) 5,131 (3.4) 3,837 (2.5)
≥ 80 3,774 (2.5) 1,978 (1.3) 1,796 (1.2)
Total 152,564 (100) 35,370 (34.05) 117,194 (65.95)
*Data presented as n (%); †male:female ratio is 1:3.31. TCM = traditional Chinese medicine.
Discussion
The current study, the first large-scale survey of the
use of CHM in the treatment of constipation in a
Chinese population, analyzed the claims dataset of
TCM office visits covered by the NHI in Taiwan. Our
results showed that females were dominant among
TCM users, which is in agreement with the results of
a systematic review by Peppas et al,3 who reported that
for those aged between 20 and 29 years, the female-
to-male ratio was 8.1. Chiarelli et al12 proposed that
hormonal factors may contribute to constipation in
women. Progesterone secreted during the luteal phase
of the menstrual cycle or during gestation is thought to
decrease the intestinal transit time, leading to consti-
pation.12 In addition, we also found that most people
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Table 2. Top 10 Chinese herbal formulae prescribed for constipation in Taiwan during 2004*
Chinese herbal formulae 
Ingredients Prescriptions, n (%)
(Chinese name)
Ma-zi-ren-wan Cannabis sativa, Paeonia lactiflora, Citrus aurantium, Rheum palmatum, 133,288 (34.4)
Magnolia officinalis, Prunus armeniaca
Fang-feng-tong-sheng-san Saposhnikovia divaricata, Forsythia suspenae, Gardenia jasminoides, 68,264 (17.6)
Schizonepeta tenuifolia, Ephedra sinica, Ligusticum chuanxiong, Angelica 
sinensis, Paeonia lactiflora, Atractylodes macrocephala, Rheum palmatum,
Mirabilite, Scutellaria baicalensis, Talcum, Gypsum Fibrosum, Mentha 
haplocalyx, Platycodon grandiflorum, Glycyrrhiza uralensis, Zingiber officinale
Run-chang-wan Angelica sinensis, Notopterygium incisum, Rheum palmatum, Prunus persica, 47,870 (12.4)
Cannabis sativa
Run-chang-tang Rheum palmatum, Angelica sinensis, Rehmannia glutinosa, Cannabis sativa, 29,927 (7.7)
Prunus persica, Prunus armeniaca, Citrus aurantium, Scutellaria baicalensis,
Magnolia  officinalis, Glycyrrhiza uralensis
Da-chai-hu-tang Bupleurum chinense, Scutellaria baicalensis, Paeonia lactiflora, Pinellia ternate, 25,504 (6.6)
Citrus aurantium, Rheum palmatum, Ziziphus jujuba, Zingiber officinale
Ping-wei-san Atractylodes lancea, Magnolia officinalis, Citrus reticulate, Glycyrrhiza uralensis, 18,885 (4.9)
Zingiber officinale, Ziziphus jujuba
Mu-xiang-bin-lang-wan Saussurea lappa, Areca cathechu, Rheum palmatum, Coptis chinensis, 18,689 (4.8)
Phellodendron amurense, Cyperus rotundus, Ipomoea nil, Citrus reticulate,
Citrus reticulate (unripe), Curcuma phaeocaulis, Citrus aurantium, Sparganium 
stoloniferum, Mirabilite
San-huang-xie-xin-tang Rheum palmatum, Coptis chinensis, Scutellaria baicalensis 18,081 (4.7)
Tao-ren-cheng-qi-tang Prunus persica, Rheum palmatum, Cinnamomum cassia, Glycyrrhiza 17,935 (4.6)
uralensis, Mirabilite
Gan-lu-yin Rehmannia gultinosa, Asparagus cochinchinensis, Ophiopogon japonicus, 17,482 (4.5)
Dendrobium nobile, Artemisia scoparia, Eriobotrya japonica, Scutellaria 
baicalensis, Citrus aurantium, Glycyrrhiza uralensis
*Total number of prescriptions = 387,268.
Table 3. Top 10 single Chinese herbs prescribed for constipation in Taiwan during 2004*
Single Chinese herb (Chinese name) Generic name Prescriptions, n (%)
Da-huang Rheum palmatum 71,133 (18.4)
Hou-pu Magnolia officinalis 25,379 (6.6)
Xuan-shen Scrophularia ningpoensis 24,528 (6.3)
Zhi-shi (fruit) Citrus aurantium 23,443 (6.1)
Sheng-di-huang Rehmannia glutinosa 23,212 (6.0)
Mai-dong Ophiopogon japonicus 23.052 (6.0)
Shan-zha Crataegus pinnatifida 22,055 (5.7)
Huo-ma-zen Cannabis sativa 19,708 (5.1)
Gan-cao Glycyrrhiza uralensis 19,273 (5.0)
Zhi-ke (peel) Citrus aurantium 17,501 (4.5)
*Total number of prescriptions = 387,268.
using TCM for constipation were between 20 and 
29 years of age (25.5%), followed by those between
30 and 39 years of age (19.6%), with the majority being
females. This result is different from the findings
reported by Higgins and Johanson,13 who showed an
increase in the prevalence of constipation with age.
Further studies are needed to clarify this issue and reveal
other causes.
Rheum palmatum, the most common single Chinese
herb for constipation, is also a component of 8 of the 10
most commonly used herbal formulae for constipation.
Rheum palmatum was first recorded in the classical
Chinese medical tome “Shennongbencaojing”, the ear-
liest Materia Medica in China, before 25–225 AD. At
that time, Rheum palmatum was used as a type of purga-
tive agent. The major bioactive constituents of Rheum
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Figure 1. The number of combinations of Chinese herbal medicine related to the number of prescriptions. The most common combina-
tion of Chinese herbal medicine used for treating constipation was 5, followed by 4 and then 3 items of Chinese herbal formulae or sin-
gle herbs. There was a mean of 4.6 Chinese herbal items in a single prescription for subjects with constipation.
Table 4. Most common prescription patterns of a 2-drug combination of Chinese herbs in a single prescription for constipation in
Taiwan during 2004*
Chinese herbal formulae or single herbs Support (%) Prescription number
Ban-xia-xie-xin-tang plus Ma-zi-ren-wan 0.7 2,855
Shao-yao-gan-cao-tang plus Ma-zi-ren-wan 0.7 2,781
Yi-zi-tang plus Ma-zi-ren-wan 0.6 2,441
Platycladus orientalis plus Ma-zi-ren-wan 0.6 2,301
San-huang-xie-xin-tang plus Ma-zi-ren-wan 0.6 2,297
Xie-fu-zhu-yu-tang plus Ma-zi-ren-wan 0.6 2,209
Liu-wei-di-huang-wan plus Ma-zi-ren-wan 0.6 2,203
Gan-lu-yin plus Run-chang-wan 0.6 2,150
Da-huang-mu-dan-pi-tang plus Ma-zi-ren-wan 0.5 2,097
Cyperus rotundus plus Ma-zi-ren-wan 0.5 2,087
*Total number of prescriptions = 387,268.
palmatum are phenolic compounds, among which sen-
nosides and anthraquinone glycosides are considered to
be the main purgative components.14 This stimulant lax-
ative or its metabolites in the human body can stimu-
late the intestinal wall, enhance intestinal peristalsis, or
change the transport of liquid and electrolytes, thereby
enhancing gastrointestinal secretion and leading to
purgation.15 Besides Rheum palmatum, other Chinese
herbs also have the ability to modulate gastrointestinal
function. Mirabilite (sodium sulfate decahydrate) has
been reported to have osmotic laxative activity through
poor absorption of sulfate, which increases osmotic pres-
sure and results in water and electrolytes being retained
in the intestinal cavity.16 Ipomoea nil extracts may affect
the ion transport of rat intestinal epithelia, leading to
water movement.17 The aqueous crude extract of
Prunus persica possesses spasmogenic activity in isolated
guinea pig ileum, which may be partially through the
cholinergic pathway.18 In animal experiments, the con-
stituent arecoline in Areca catechu can stimulate colonic
motility through muscarinic acetylcholine receptors.19
Angelica sinensis may possess the ability to react with
serotonin receptors and then promote serotonergic
activity, thereby stimulating intestinal motility.20,21
The active ingredient in Rehmannia glutinosa,
catalpol, is an iridoid glycoside,22,23 and Gardenia jas-
minoides, which contains iridoid, may also possess pur-
gative activity.24 In ritonavir-treated rats with slower
gastric emptying capability, gastrointestinal dysfunction
is improved after administration of a Scutellaria bai-
calensis extract.25 Zingiber officinale can speed up gas-
trointestinal transit in mice fed with a charcoal meal.26
The water-soluble components of Zizyphus jujuba can
reduce gastrointestinal transit time, thus enhancing
water retention in feces.27
The components of commonly used herbal formu-
lae for treating constipation mostly have a purgation
effect, as described above by modern pharmacology.
However, there are some Chinese herbs that have an
opposite pharmacological function. For example, can-
nabidiol is a Cannabis sativa-derived compound that
can selectively inhibit croton oil-induced intestinal
hypermotility in mice,28 and decrease gastrointestinal
movement.29 Cyperus rotundus possesses antidiarrheal
activity.30 These Chinese herbs, which decrease gastro-
intestinal movement, have been used for the treatment
of constipation. Different pharmacological functions
may be due to the difference between a pure compound
and a crude extract of the herb, or the combined effects
of multi-component formulations, or through different
pathological mechanisms. How 1 Chinese herb can
exert effects that are diametrically opposed is still not
fully understood and deserves further investigation.
Glycycoumarin is 1 active component in Glycyrrhiza
uralensis. It has an antispasmodic effect on the con-
traction of mouse jejunum through inhibition of the
phosphodiesterase 3 mechanism.31 Other Chinese
medicines such as Magnolia officinalis,32 Mentha sp.,33
and Paeonia lactiflora34 have a spasmolytic effect, which
could possibly be beneficial for spasmodic constipa-
tion.35 In isolated animal tissue, the aqueous-methanol
crude extract of Saussurea lappa possesses a spasmogenic
effect through the cholinergic pathway. However,
under conditions such as a higher drug concentration
or intestinal hypermotility, the spasmolytic effect ap-
pears through a calcium channel blocker mechanism.36
Therefore, even for the same Chinese herb, there may
be different pharmacological functions with different
dosages or physical conditions.
Among the top 10 single Chinese herbs prescribed
for constipation, Scrophularia ningpoensis contains a
bioactive compound, iridoid, which possibly possesses
a purgative effect,23 and Crataegus pinnatifida was
once reported to have an antispasmodic effect.37 In the
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Table 5. Most common prescription patterns of a 3-drug combination of Chinese herbs in a single prescription for constipation in
Taiwan during 2004*
Chinese herbal formulae or single herbs Support (%) Prescription number
Fang-feng-tong-sheng-sa, Rheum palmatum and Ma-zi-ren-wan 0.6 2,462
Angelica sinensis, Cistanche tubulosa and Ma-zi-ren-wan 0.5 1,817
Citrus aurantium, Magnolia officinalis and Ma-zi-ren-wan 0.4 1,405
Rehmannia glutinosa, Fang-feng-tong-sheng-san and Rheum palmatum 0.3 1,280
Areca catechu, Saussurea lappa and Ma-zi-ren-wan 0.3 1,223
Da-chai-hu-tang, Fang-feng-tong-sheng-san and Rheum palmatum 0.3 1,177
Crataegus pinnatifida, Fang-feng-tong-sheng-san and Ma-zi-ren-wan 0.3 1,164
Run-chang-tang, Rheum palmatum and Ma-zi-ren-wan 0.3 1,083
Citrus aurantium, Rheum palmatum and Ma-zi-ren-wan 0.3 1,074
Run-chang-wan, Rheum palmatum and Ma-zi-ren-wan 0.3 1,060
*Total number of prescriptions = 387,268.
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classification of Chinese medicine, Ophiopogon japoni-
cus is categorized as a Yin-tonifying medicinal, capa-
ble of nourishing Yin fluid and therefore moistening
the intestine.
In the top 10 Chinese herbal formulae prescribed
for constipation, Fang-feng-tong-sheng-san (Bofu-
tsusho-san in Japanese) is usually used to combat
obesity.38 Da-chai-hu-tang extracts and San-huang-
xie-xin-tang extracts relax smooth muscle tone in the
gastrointestinal tract through phosphodiesterase inhi-
bition, and are therefore capable of treating spasmodic
constipation.39 Ping-wei-san is usually applied for the
treatment of heartburn and gastritis.40 It is worth not-
ing that Fang-feng-tong-sheng-san and Da-chai-hu-tang
have been reported to cause interstitial pneumonia or
hepatitis during clinical practice.41,42 It is often difficult
to completely understand the underlying mechanisms.
Therefore, it is necessary to conduct randomized,
double-blinded, placebo-controlled trials to assess the
efficacy and safety of these Chinese medicines in patients
with constipation. Additionally, Cistanche tubulosa con-
tains iridoid glycosides, and thus possibly has purga-
tive effects.43 Ban-xia-xie-xin-tang is reported to have
antidiarrheal activity,44 and Shao-yao-gan-cao-tang has
an antispasmodic effect.45
In our study, an average of 4.6 items, either Chinese
herbal formulae or single herbs, were contained in each
prescription for constipation. According to our results,
the most commonly prescribed CHM drug combina-
tion for treating constipation was mainly an herbal
formula and single herb.
This study was a retrospective analysis of the use of
CHM to treat constipation. Unlike clinical trials, which
can provide direct evidence of efficacy, many herbs in
the herbal formulae or single herbs frequently pre-
scribed have been found to contain ingredients that as-
sist defecation via varied mechanisms as discussed above.
In fact, the principle of TCM treatment is different
from that of Western medicine, as TCM involves the
patient’s constitutional needs, e.g. Bianzheng Lunzhi
( , syndrome differentiation and treatment),46
and therefore, it is difficult to create a constitutionally-
matched control group. With regard to the treatment
of constipation, although Chinese and Western medi-
cine view the causes of the disease differently, both are
in agreement that constipation is a symptom rather than
a diagnosis. TCM treatment for constipation is based
on the syndrome of its subclassification; for example, if
the symptoms include a dry mouth, yellow urine, a red
tongue and surging pulse, it is subclassified as excess
syndrome ( ) for which a formula such as Ma-zi-ren-
wan can be prescribed, as it can discharge excessive
heat.47 On the other hand, if the symptoms include
fatigue, a pale complexion, pale tongue and a thready,
weak pulse, it is subclassified as deficient syndrome
( ). Therefore, a formula or single herb that can nour-
ish Qi and Yin will be administered; in this case, Run-
chang-tang or Ophiopogon japonicus is a good choice.
In young people, constipation is mostly subclassified
as excess syndrome, which may explain why this study
found Ma-zi-ren-wan to be the formula most com-
monly prescribed for the treatment of constipation.
In conclusion, based on the availability of electronic
health care claims data in Taiwan, a population-based
survey of Chinese herbal pharmacoepidemiology on
constipation determined the frequency of use and pat-
terns of prescriptions in a Chinese population. Never-
theless, the therapeutic effects and safety of those herbal
formulae or single herbs used requires further eluci-
dation through efficiency-based clinical studies or
well-designed randomized, double-blinded, placebo-
controlled trials.
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Angelica sinensis
Areca catechu
Artemisia scoparia
Asparagus cochinchinensis
Atractylodes lancea
Atractylodes macrocephala
Bupleurum chinense
Cannabis sativa
Cinnamomum cassia
Citrus aurantium
Citrus reticulate
Cistanche tubulosa
Coptis chinensis
Crataegus pinnatifida
Curcuma phaeocaulis
Cyperus rotundus
Dendrobium nobile
Ephedra sinica
Eriobotrya japonica
Forsythia suspense
Gardenia jasminoides
Glycyrrhiza uralensis
Gypsum Fibrosum
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Appendix I. Summary of the scientific and Chinese equivalents of herbs and names appearing in this article
Appendix II. Summary of the English (Hanyu Pinyin) and Chinese equivalents of formulae and names appearing in this article
An-zhong-san
Ban-xia-xie-xin-tang
Da-chai-hu-tang
Da-huang-mu-dan-pi-tang
Fang-feng-tong-sheng-san
Gan-lu-yin
Liu-wei-di-huang-wan
Ma-zi-ren-wan
Mu-xiang-bin-lang-wan
Ping-wei-san
Run-chang-tang
Run-chang-wan
San-huang-xie-xin-tang
Shao-yao-gan-cao-tang
Tao-ren-cheng-qi-tang
Xie-fu-zhu-yu-tang
Yi-zi-tang Ԭڗྏ
ۨࢌດᅟྏ
௒ոʻுʼࢭ௛ྏ
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ڜխཋ
Ligusticum chuanxiong
Magnolia officinalis
Mentha haplocalyx
Mirabilite (sodium sulfate decahydrate)
Notopterygium incisum
Ophiopogon japonicus
Paeonia lactiflora
Phellodendron amurense
Pinellia ternate
Platycladus orientalis
Platycodon grandiflorum
Prunus armeniaca
Prunus persica
Rehmannia glutinosa
Rheum palmatum
Saposhnikovia divaricata
Saussurea lappa
Schizonepeta tenuifolia
Scrophularia ningpoensis
Scutellaria baicalensis
Sparganium stoloniferum
Talcum
Zingiber officinale
Ziziphus jujuba Օའ
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